118 related articles for article (PubMed ID: 38372107)
1. TMCO1 regulates cell proliferation, metastasis and EMT signaling through CALR, promoting ovarian cancer progression and cisplatin resistance.
Sun G; Gong S; Lan S; He Y; Sun Y; Zhang Z
Cell Mol Biol (Noisy-le-grand); 2024 Jan; 70(1):99-109. PubMed ID: 38372107
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-302 represses epithelial-mesenchymal transition and cisplatin resistance by regulating ATAD2 in ovarian carcinoma.
Ge T; Liu T; Guo L; Chen Z; Lou G
Exp Cell Res; 2020 Nov; 396(1):112241. PubMed ID: 32835657
[TBL] [Abstract][Full Text] [Related]
3. Impact of Selected Signaling Proteins on SNAIL 1 and SNAIL 2 Expression in Ovarian Cancer Cell Lines in Relation to Cells' Cisplatin Resistance and EMT Markers Level.
Kielbik M; Szulc-Kielbik I; Klink M
Int J Mol Sci; 2021 Jan; 22(2):. PubMed ID: 33478150
[TBL] [Abstract][Full Text] [Related]
4. TMCO1 expression promotes cell proliferation and induces epithelial-mesenchymal transformation in human gliomas.
Gao L; Ye Z; Liu JH; Yang JA; Li Y; Cai JY; Wang YX; Tong SA; Deng G; Zhang S; Chen QX
Med Oncol; 2022 May; 39(5):90. PubMed ID: 35568751
[TBL] [Abstract][Full Text] [Related]
5. [miR-497 inhibits the growth and metastasis of SGC-7901 human gastric cancer anoikis resistant cells via blocking Wnt/β-catenin signaling pathway].
Yu L; Xu Y; Yang J; Gao L; Li H; Wang Z; Zhang Z; Ling Y
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2023 Jul; 39(7):617-625. PubMed ID: 37403721
[TBL] [Abstract][Full Text] [Related]
6. FAT4 silencing promotes epithelial-to-mesenchymal transition and invasion via regulation of YAP and β-catenin activity in ovarian cancer.
Malgundkar SH; Burney I; Al Moundhri M; Al Kalbani M; Lakhtakia R; Okamoto A; Tamimi Y
BMC Cancer; 2020 May; 20(1):374. PubMed ID: 32366234
[TBL] [Abstract][Full Text] [Related]
7. Human chorionic gonadotropin β regulates epithelial-mesenchymal transition and metastasis in human ovarian cancer.
Liu N; Peng SM; Zhan GX; Yu J; Wu WM; Gao H; Li XF; Guo XQ
Oncol Rep; 2017 Sep; 38(3):1464-1472. PubMed ID: 28713970
[TBL] [Abstract][Full Text] [Related]
8. UBP43 promotes epithelial ovarian carcinogenesis via activation of β-catenin signaling pathway.
Xie H; Chen J; Ma C; Zhao J; Cui M
Cell Biol Int; 2023 Aug; 47(8):1427-1440. PubMed ID: 37186433
[TBL] [Abstract][Full Text] [Related]
9. HPIP promotes epithelial-mesenchymal transition and cisplatin resistance in ovarian cancer cells through PI3K/AKT pathway activation.
Bugide S; Gonugunta VK; Penugurti V; Malisetty VL; Vadlamudi RK; Manavathi B
Cell Oncol (Dordr); 2017 Apr; 40(2):133-144. PubMed ID: 28039608
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of
Wu L; Ling ZH; Wang H; Wang XY; Gui J
Cancer Biother Radiopharm; 2019 Dec; 34(10):642-649. PubMed ID: 31549859
[No Abstract] [Full Text] [Related]
11. Calreticulin increases growth and progression of natural killer/T-cell lymphoma.
Zheng Y; Li C; Xin P; Peng Q; Zhang W; Liu S; Zhu X
Aging (Albany NY); 2020 Nov; 12(23):23822-23835. PubMed ID: 33221760
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-506 inhibits tumor growth and metastasis in nasopharyngeal carcinoma through the inactivation of the Wnt/β-catenin signaling pathway by down-regulating LHX2.
Liang TS; Zheng YJ; Wang J; Zhao JY; Yang DK; Liu ZS
J Exp Clin Cancer Res; 2019 Feb; 38(1):97. PubMed ID: 30791932
[TBL] [Abstract][Full Text] [Related]
13. Establishment of Acquired Cisplatin Resistance in Ovarian Cancer Cell Lines Characterized by Enriched Metastatic Properties with Increased Twist Expression.
Bahar E; Kim JY; Kim HS; Yoon H
Int J Mol Sci; 2020 Oct; 21(20):. PubMed ID: 33076245
[TBL] [Abstract][Full Text] [Related]
14. Notch1 Affects Chemo-resistance Through Regulating Epithelial-Mesenchymal Transition (EMT) in Epithelial Ovarian cancer cells.
Qian XQ; Tang SS; Shen YM; Chen LL; Cheng XD; Wan XY
Int J Med Sci; 2020; 17(9):1215-1223. PubMed ID: 32547317
[No Abstract] [Full Text] [Related]
15. BRMS1L suppresses ovarian cancer metastasis via inhibition of the β-catenin-wnt pathway.
Cao P; Zhao S; Sun Z; Jiang N; Shang Y; Wang Y; Gu J; Li S
Exp Cell Res; 2018 Oct; 371(1):214-221. PubMed ID: 30118697
[TBL] [Abstract][Full Text] [Related]
16. The role of nuclear β-catenin accumulation in the Twist2-induced ovarian cancer EMT.
Mao Y; Xu J; Li Z; Zhang N; Yin H; Liu Z
PLoS One; 2013; 8(11):e78200. PubMed ID: 24244294
[TBL] [Abstract][Full Text] [Related]
17. Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial-mesenchymal transition.
Yu J; Han Q; Cui Y
Tumour Biol; 2017 Jul; 39(7):1010428317709129. PubMed ID: 28691641
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of
Tian J; Li Z; Jiang Y; Gu W; Kong E; Hao Q; Kong B; Sun L
Rejuvenation Res; 2022 Oct; 25(5):243-252. PubMed ID: 36039935
[TBL] [Abstract][Full Text] [Related]
19. Ribosomal L22-like1 (RPL22L1) Promotes Ovarian Cancer Metastasis by Inducing Epithelial-to-Mesenchymal Transition.
Wu N; Wei J; Wang Y; Yan J; Qin Y; Tong D; Pang B; Sun D; Sun H; Yu Y; Sun W; Meng X; Zhang C; Bai J; Chen F; Geng J; Lee KY; Fu S; Jin Y
PLoS One; 2015; 10(11):e0143659. PubMed ID: 26618703
[TBL] [Abstract][Full Text] [Related]
20. NANOG regulates epithelial-mesenchymal transition and chemoresistance through activation of the STAT3 pathway in epithelial ovarian cancer.
Liu S; Sun J; Cai B; Xi X; Yang L; Zhang Z; Feng Y; Sun Y
Tumour Biol; 2016 Jul; 37(7):9671-80. PubMed ID: 26801672
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]